Abstract
Neuronal leucine-rich repeat protein-1 (NLRR1) gene encodes a type I transmembrane protein with unknown function. We have previously described that NLRR1 gene is highly expressed in unfavorable neuroblastomas as compared with favorable tumors and its higher expression levels correlate significantly with poor clinical outcome. In this study, we have found that NLRR1 gene is one of direct target genes for N-MYC and its gene product contributes to N-MYC-dependent growth promotion in neuroblastoma. Expression levels of NLRR1 were significantly associated with those of N-MYC in various neuroblastoma cell lines as well as primary neuroblastoma tissues. Indeed, enforced expression of N-MYC resulted in a remarkable induction of the endogenous NLRR1. Consistent with these results, we have identified two functional E-boxes within the promoter region and intron 1 of NLRR1 gene. Intriguingly, c-myc also transactivated NLRR1 gene. Enforced expression of NLRR1 promoted cell proliferation and rendered cells resistant to serum deprivation. In support with these observations, small-interfering RNA-mediated knockdown of the endogenous NLRR1-reduced growth rate and sensitized cells to serum starvation. Collectively, our present findings provide a novel insight into understanding molecular mechanisms behind aggressive neuroblastoma with N-MYC amplification.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alex R, Sozeri O, Meyer S, Dildrop R . (1992). Determination of the DNA sequence recognized by the bHLH-zip domain of the N-Myc protein. Nucleic Acids Res 20: 2257–2263.
Bando T, Sekine K, Kobayashi S, Watabe AM, Rump A, Tanaka M et al. (2005). Neuronal leucine-rich repeat protein 4 functions in hippocampus-dependent long-lasting memory. Mol Cell Biol 25: 4166–4175.
Bernards R, Dessain SK, Weinberg RA . (1986). N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma. Cell 47: 667–674.
Blackwood EM, Eisenman RN . (1991). Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA binding complex with Myc. Science 251: 1211–1217.
Blackwood EM, Kretzner I, Eisenman RN . (1992). Myc and Max function as a nucleoprotein complex. Curr Opin Genet Dev 2: 227–235.
Boon K, Caron HN, van Asperen R, Valentijn L, Hermus MC, van Sluis P et al. (2001). N-myc enhances the expression of a large set of genes functioning ribosome biogenesis and protein synthesis. EMBO J 20: 1383–1393.
Brodeur GM, Nakagawara A . (1992). Molecular basis of clinical heterogeneity in neuroblastoma. Am J Pediatr Hematol Oncol 14: 111–116.
Degterev A, Boyce M, Yuan J . (2003). A decade of caspases. Oncogene 22: 8543–8567.
Fukamachi K, Matsuoka Y, Ohno H, Hamaguchi T, Tsuda H . (2002). Neuronal leucine-rich repeat protein-3 amplifies MAPK activation by epidermal growth factor through a carboxyl-terminal region containing endocytosis motifs. J Biol Chem 277: 43549–43552.
Hamano S, Ohira M, Isogai E, Nakada K, Nakagawara A . (2004). Identification of novel human neuronal leucine-rich repeat (hNLRR) family, genes and inverse association of expression of Nbla10449/hNLRR-1 and Nbla10677/hNLRR-3 with the prognosis of primary neuroblastomas. Int J Oncol 24: 1457–1466.
Kohl NE, Kanda N, Schreck RR, Bruns G, Latt SA, Gilbert F et al. (1983). Transposition and amplification of oncogene-related sequences in human neuroblastomas. Cell 35: 359–367.
Kouzarides T, Ziff E . (1988). The role of the leucine zipper in the fos-jun interaction. Nature 336: 646–651.
Landschulz WH, Johnson PF, McKnight S . (1988). The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science 240: 1759–1764.
Lasorella A, Noseda M, Beyna M, Iavarone A . (2000). Id2 is a retinoblastoma protein target and mediates signaling by Myc oncoproteins. Nature 407: 592–598.
Lutz W, Stohr M, Schurmann J, Wenzel A, Lohr A, Schwab M . (1996). Conditional expression of N-myc in human neuroblastoma cells increases expression of a-prothymosin and ornithine decarboxylase and accelerates progression into S-phase early after mitogenic stimulation of quiescent cells. Oncogene 13: 803–812.
Murre C, Schonleber McCaw P, Baltimore D . (1989). A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell 56: 777–783.
Negroni A, Scarpa S, Romeo A, Ferrari S, Modesti A, Raschella G . (1991). Decrease of proliferation rate and induction of differentiation by a MYCN antisense DNA oligomer in a human neuroblastoma cell line. Cell Growth Differ 2: 511–518.
Schwab M, Alitalo K, Klempnauer KH, Varmus HE, Bishop JM, Gilbert F et al. (1983). Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumour. Nature 305: 245–248.
Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY et al. (1985). Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313: 1111–1116.
Slack A, Chen Z, Tonelli R, Pule M, Hunt L, Pession A et al. (2005). The p53 regulatory gene MDM2 is a direct transcriptional target of MYCN in neuroblastoma. Proc Natl Acad Sci USA 102: 731–736.
Taguchi A, Wanaka A, Mori T, Matsumoto K, Imai Y, Takagi T et al. (1996). Molecular cloning of novel leucine-rich repeat proteins and their expression in the developing mouse nervous system. Brain Res Mol Brain Res 35: 31–40.
Taniguchi H, Tohyama A, Takagi T . (1996). Cloning and expression of a novel gene for a protein with leucine-rich repeats in the developing mouse nervous system. Brain Res Mol Brain Res 36: 45–52.
Torres R, Schreiber-Agus N, Morgenbesser SD, DePinho RA . (1992). Myc and Max: a putative transcriptional complex in search of a cellular target. Curr Opin Cell Biol 4: 468–474.
Truscott M, Denault JB, Goulet B, Leduy L, Salvesen GS, Nepveu A . (2007). Carboxy-terminal proteolytic processing of CUX1 by a caspase enables transcriptional activation in proliferating cells. J Biol Chem 282: 30216–30226.
Wang J, Xie I, Allan S, Beach D, Hannon G . (1998). Myc activates telomerase. Genes Dev 12: 1769–1774.
Weiss WA, Aldape K, Mohapatra G, Feuerstein BG, Bishop JM . (1997). Targeted expression of MYCN causes neuroblastoma in transgenic mice. EMBO J 16: 2985–2995.
Acknowledgements
We are grateful to Dr M Schwab for providing the expression plasmid for N-MYC. We thank Ms Y Nakamura for technical assistance. This work was supported in part by a Grant-in-Aid from the Ministry of Health, Labour and Welfare for Third Term Comprehensive Control Research for Cancer, a Grant-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan, a Grant-in-Aid for Scientific Research from Japan Society for the Promotion of Science, Uehara Memorial Foundation and Hisamitsu Pharmaceutical Co.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)
Rights and permissions
About this article
Cite this article
Hossain, M., Ozaki, T., Wang, H. et al. N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma. Oncogene 27, 6075–6082 (2008). https://doi.org/10.1038/onc.2008.200
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2008.200
Keywords
This article is cited by
-
Prognostic value and biological function of LRRN4 in colorectal cancer
Cancer Cell International (2022)
-
Transcriptional landscape of PTEN loss in primary prostate cancer
BMC Cancer (2021)
-
Identification of a prognostic 5-Gene expression signature for gastric cancer
Journal of Cancer Research and Clinical Oncology (2017)
-
Neuronal leucine-rich repeat 1 negatively regulates anaplastic lymphoma kinase in neuroblastoma
Scientific Reports (2016)
-
Identifying LRRC16B as an oncofetal gene with transforming enhancing capability using a combined bioinformatics and experimental approach
Oncogene (2011)